Safety of propafenone application in patients with organic myocardial pathology at the prehospital stage
https://doi.org/10.24884/2072-6716-2021-22-2-32-37
Abstract
In the course of the study, a group of patients with paroxysms of atrial fibrillation and organic myocardial pathology was identified, who were treated with the antiarrhythmic 1C class propafenone at the pre-hospital stage to control the rhythm. The effect of propafenone on hemodynamics in patients with and without organic myocardial pathology was compared.
About the Authors
I. G. Trukhanova
Samara State Medical University
Russian Federation
Russian Federation
Inna G. Trukhanova
D. S. Zinnatullina
Samara State Medical University
Russian Federation
Russian Federation
Dilyara S. Zinnatullina
I. A. Polyakov
Samara State Medical University
Russian Federation
Russian Federation
Igor’ A. Polyakov
S. Kh. Sadreeva
Samara State Medical University
Russian Federation
Russian Federation
References
1. Clinical guidelines for the diagnosis and treatment of atrial fibrillation. Russian Scientific Society of Specialists in Clinical Electrophysiology, Arrhythmology and Electrocardiostimulation (VNOA) in cooperation with the Russian Society of Cardiology (RKO) and the Association of Cardiovascular Surgeons, 2017 (In Russ.).
2. Katritsis D.G., Gersh B. J., Camm A. J. Clinical Cardiology: Current Practice Guidelines. Oxford University Press, 2016. 968 р.
3. Ferri F. F. Ferri’s Clinical Advisor 2019 E-Book: 5 Books in 1. Elsevier Health Sciences, 2019. Р. 164.
4. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) / Brignole M., Auricchio A. et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy // Rev. Esp. Cardiol. (Engl. еd.). 2014. Vol. 67, No 1. Р. 58. doi: 10.1016/j.rec.2013.11.003.
5. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC // Eur. Heart J. https://doi.org/10.1093/eurheartj/ehaa612.
6. 2016 ESC guildelines for the management of atrial fibrillation developed in collaboration with EACTS. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA) of the ESC // Eur. Heart J. 2016. Vol. 37, No 38. Р. 2893–2962. doi: https://doi.org/10.1093/eurheartj/ehw210.
7. Emergency care. Clinical recommendations / ed. by S. F. Bagnenko. Moscow: Publishing house GEOTAR-Media, 2020. 896 р. (In Russ.).
8. Shlyakhto E. V. Cardiology: national guidelines. 2nd ed., reprint. and additional. Moscow: Publishing house GЕOTAR-Media, 2015, 800 p. (In Russ.).
9. Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E. J. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study // Circulation. 2014. Vol. 25, No 129 (8). Р. 837– 847. doi: 0.1161/CIRCULATIONAHA.113.005119.
10. Kolbin A. S., Mosikyan A. A., Tatarsky B. A. Socio-economic burden of atrial fibrillation in Russia: dynamics over 7 years (2010–2017). Bulletin of Arrhythmology, 2018, No 92, pp. 42–48 (In Russ.) doi: 10.25760/VA-2018–92–42–48.
11. Beyond the burden: the impact of atrial fibrillation in Аsia pacific. 2019 Report.
12. Zoni-Berisso M., Lercari F., Carazza T., Domenicucci S. Epidemiology of atrial fibrillation: European perspective // Clin. Epidemiol. 2014. Vol. 6. Р. 213–220. Published 2014 Jun 16. doi: 10.2147/CLEP.S47385.
13. Polyakov I. A., Trukhanova I. G., Zinnatullina D. S. Emergency care for patients with atrial fibrillation at the prehospital stage: a modern view of the problem. Practical medicine, 2020, Vol. 18, No 1, pp. 13–17 (In Russ.) doi: 10.32000/2072–1757–2020–1–13–17.
14. Plavun ov N. F., Gaponova N. I., Kadyshev V. A., Abdrakhmanov V. R., Akimov A. E., Kulik A. I. Clinical and statistical analysis of patients with atrial fibrillation. Archive of Internal Medicine, 2018, Vol. 8, No 5, рр. 389–393 (In Russ.) doi: 10.20514/2226–6704–2018–8–5–389–393
15. Severino P., Mariani M. V., Maraone A. et al. Triggers for Atrial Fibrillation: The Role of Anxiety // Cardiol. Res. Pract. 2019. Vol. 2019. 1208505. Published 2019 Feb. 18. doi: 10.1155/2019/1208505.
16. Demenko T. N., Chumakova G. A. Psychological status and quality of life of patients with different forms of atrial fibrillation. Siberian Medical Review, 2017, Vol. 4, No 106. (In Russ.).
17. Lukyanova I. Yu., Kuznetsov A. V., Sokolov Yu. V. Medical cardioversion with propafenone in patients with paroxysmal atrial fibrillation at the prehospital stage. Emergency medical care, 2017, No 2, р. 31 (In Russ.).
18. Miller O. N., Syrov A. V., Doschitsin V. L. et al. Clinical recommendations and expert opinions on the use of antiarrhythmic drugs in real practice. Consilium Medicum, 2019, Vol. 21, No 5, рр . 43–50 (In Russ.).
19. Tarasov A. V., Kosykh S. A., Bushueva E. V. et al. Comparison of the effectiveness of injectable forms of antiarrhythmic drugs propafenone and amiodarone in pharmacological cardioversion of paroxysmal atrial fibrillation. Consilium Medicum, 2019, Vol. 21, No 1, рр. 81–86 (In Russ.).
20. Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. August 10, 1989 // N. Engl. J. Med. 1989. Vol. 321. Р. 406–412. doi: 10.1056/NEJM198.908.103210629.
21. Greene H., Roden D., Katz R. et al. The Cardiac Arrhythmia Suppression Trial: first CAST… then CAST-II // J. Am. Coll Cardiol. 1992. Vol. 19, No 5. Р. 894–898.
Review
For citations:
Trukhanova I.G., Zinnatullina D.S., Polyakov I.A., Sadreeva S.Kh. Safety of propafenone application in patients with organic myocardial pathology at the prehospital stage. EMERGENCY MEDICAL CARE. 2021;22(2):32-37. (In Russ.) https://doi.org/10.24884/2072-6716-2021-22-2-32-37
Views:
446
Email this article 